The terms assert that all genetic information provided by 23andMe is for research, informational, and educational use only, that many reported findings have not been clinically validated, and that 23andMe does not endorse or warrant any course of action, product, or healthcare provider mentioned on its platform.
This analysis describes what 23andMe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision limits the scope of 23andMe's representations about the clinical applicability of its genetic reports and explicitly disclaims medical advisory or diagnostic function. These disclaimers are operationally significant in the context of liability for health-related decisions made in reliance on 23andMe results, and their enforceability may depend on how regulatory authorities classify the company's services.
Under this clause, users are advised that genetic results are not clinically validated for diagnostic purposes, and the agreement states that reliance on 23andMe information for health decisions is at the user's own risk. The terms do not disclaim the company's California clinical laboratory license, but note that licensure is not universal across all jurisdictions.
Cross-platform context
See how other platforms handle Medical Disclaimer and Research Use Limitation and similar clauses.
Compare across platforms →"Please note, the Genetic Information provided by 23andMe is for research, informational, and educational use only. This means two things: Many of the genetic discoveries that we report have not been clinically validated, and the technology we use, which is the same technology used by the research community, to date has not been widely used for clinical testing. Talk to your Healthcare provider. 23andMe does not endorse, warrant or guarantee the effectiveness of any specific course of action, resources, tests, physician or other healthcare providers, drugs, biologics, medical devices or other products, procedures, opinions, or other information that may be mentioned on our website.Excerpt from 23andMe's Terms of Service
(1) REGULATORY LANDSCAPE: The FDA regulates laboratory developed tests and direct-to-consumer genetic tests; 23andMe has previously engaged with FDA oversight for specific health-related genetic reports.
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision limits the scope of 23andMe's representations about the clinical applicability of its genetic reports and explicitly disclaims medical advisory or diagnostic function. These disclaimers are operationally significant in the context of liability for health-related decisions made in reliance on 23andMe results, and their enforceability may depend on how regulatory authorities classify the company's services.
Under this clause, users are advised that genetic results are not clinically validated for diagnostic purposes, and the agreement states that reliance on 23andMe information for health decisions is at the user's own risk. The terms do not disclaim the company's California clinical laboratory license, but note that licensure is not universal across all jurisdictions.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by 23andMe.